IGBA Statement on trade barriers and their impact on healthcare systems and patients’ health

Ambitious Critical Medicines Act vital to secure supply

Medicines for Europe supports legal action against provisions in the Urban Wastewater Treatment Directive (UWWTD), which puts access to medicines at risk

Pharma reform brings new opportunities for better regulation, access and security of medicines supply

Harmonising Bioequivalence: Advancing Global Access to Generic Medicines

STADA’s Stephan Eder sets Access, Manufacturing and Sustainability at heart of Medicines for Europe Presidency

Industry Proposes Phased Rollout of ePI for Patient Safety and Environmental Sustainability

Maximising the impact of Biosimilar Medicines requires strategic action in Europe

Medicines for Europe Statement on Unitary SPC Legislative Process

Joint Industry Statement on EU-Mercosur Negotiations